Connect Biopharma Holdings Limited Receivables Turnover Ratio (CNTB), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Connect Biopharma Holdings Limited  (NASDAQ: CNTB)
 

Connect Biopharma Holdings Limited Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Connect Biopharma Holdings Limited's ability to collect accounts receivable sequentially worsen to 3.98, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Connect Biopharma Holdings Limited's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 92 days, from 12 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector Connect Biopharma Holdings Limited achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Connect Biopharma Holdings Limited Selling?


What is Receivable Turnover Ratio?





CNTB Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change - - -98.35 % - -
Y / Y Revenue Change 5666.67 % - - -98.69 % -99.8 %
Receivable Turnover Ratio (TTM) 3.98 31.07 6.74 128.24 137.01
CNTB's Total Ranking # # # # #
Accounts Receivable average collection period days 92 12 54 3 3
Seq. Receivable Change - - -23.53 % - -
Seq. Revenue Change 1537.87 % - - -66.67 % -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 






Financial Statements
Connect Biopharma Holdings Limited's Accounts Receivable $ 3 Millions Visit CNTB's Balance sheet
Connect Biopharma Holdings Limited's Sales TTM $ 3 Millions Visit CNTB's Income Statement
Sources of CNTB's Revenues Visit CNTB's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CNTB's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CNTB's Growth Rates CNTB's Roa CNTB's Inventory Turnover Ratio CNTB's Dividend Comparisons
CNTB's Profitability Ratios CNTB's Roi CNTB's Asset Turnover Ratio CNTB's Dividend Growth
CNTB's Valuation Ratios CNTB's Roe CNTB's Financial Strength Ratios CNTB's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Harrow Inc   2.69 $ 274.724  Millions$ 102.078  Millions
Surrozen Inc   2.66 $ 11.511  Millions$ 4.329  Millions
Electromed Inc   2.64 $ 72.076  Millions$ 27.317  Millions
Regeneron Pharmaceuticals Inc   2.62 $ 15,534.700  Millions$ 5,931.150  Millions
Onemednet Corporation  2.61 $ 1.590  Millions$ 0.609  Millions
American Shared Hospital Services  2.58 $ 30.210  Millions$ 11.732  Millions
Aclarion Inc   2.57 $ 0.084  Millions$ 0.033  Millions
Journey Medical Corp  2.50 $ 68.181  Millions$ 27.251  Millions
Cardiff Oncology Inc   2.49 $ 0.508  Millions$ 0.204  Millions
Hyperfine Inc   2.39 $ 15.425  Millions$ 6.458  Millions
Arbutus Biopharma Corp  2.35 $ 181.720  Millions$ 77.420  Millions
Tg Therapeutics Inc   2.34 $ 799.536  Millions$ 341.156  Millions
Abcellera Biologics Inc   2.30 $ 66.174  Millions$ 28.812  Millions
Cumberland Pharmaceuticals Inc   2.27 $ 31.269  Millions$ 13.764  Millions
Co diagnostics Inc   2.14 $ 0.721  Millions$ 0.337  Millions
Profound Medical Corp   2.14 $ 19.086  Millions$ 8.924  Millions
60 Degrees Pharmaceuticals Inc   2.13 $ 1.111  Millions$ 0.522  Millions
Cardio Diagnostics Holdings Inc   2.10 $ 0.014  Millions$ 0.007  Millions
Scilex Holding Company  1.93 $ 31.608  Millions$ 16.396  Millions
Ocular Therapeutix Inc   1.79 $ 52.054  Millions$ 29.007  Millions
Heron Therapeutics Inc   1.76 $ 151.507  Millions$ 85.975  Millions
Bio Green Med Solution Inc   1.75 $ 1.861  Millions$ 1.061  Millions
EBR Systems, Inc.  1.74 $ 6.446  Millions$ 3.714  Millions
Cytomx Therapeutics Inc   1.69 $ 18.302  Millions$ 10.821  Millions
Biocorrx Inc   1.67 $ 0.787  Millions$ 0.471  Millions
Prophase Labs Inc   1.59 $ 3.150  Millions$ 1.977  Millions
Amarin Corp Plcuk  1.49 $ 186.480  Millions$ 125.559  Millions
Skinvisible Inc   1.45 $ 0.020  Millions$ 0.014  Millions
Lightwave Logic Inc   1.40 $ 0.250  Millions$ 0.178  Millions
Roivant Sciences Ltd   1.39 $ 7.532  Millions$ 5.400  Millions

Date modified: 2026-09-03T11:39:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.